Illumina Ventures related stories
All articles and analysis
LetsGetChecked picks up $71m Series CNew York City and Dublin-based LetsGetChecked, a direct-to-consumer at-home health testing and insights company, has raised $71 million in Series C financing.
- Actym Therapeutics rakes in $34m Series A
Berkeley, California-based Actym Therapeutics, an immuno-oncology company, has closed $34 million in Series A financing.
- Kallyope picks up $112m Series C
New York City-based Kallyope Inc., a biotechnology company, has secured $112 million in Series C financing.
Stilla Technologies rakes in $22 mn Series BStilla Technologies, a French provider of digital PCR solutions for high-precision genetic analysis, has raised $22 million in Series B funding.
Ribometrix snags $7.8 mlnDurham, North Carolina-based Ribometrix, a biotechnology company developing small molecule therapeutics that directly target RNA to treat human diseases, has secured $7.8 million in funding. The backers are Dementia Discovery Fund and Illumina Ventures. In addition to the funding, Ribometrix has named Dr. Mike Clayman as chairman of the board of directors.
- Cradle Genomics attracts $17.1 mln
San Diego-based Cradle Genomics, a provider of a prenatal testing methodology, has secured $17.1 million in funding. Illumina Ventures and Section 32 led the round with participation from Alexandria Real Estate Equities, Sea Lane Ventures, Listwin Ventures and Axon Ventures.
- Encoded Therapeutics inks $104 mln Series C
South San Francisco-based Encoded Therapeutics Inc, a precision gene therapy company, has secured $104 million in Series C funding. The investors included Venrock, ARCH Venture Partners, Matrix Capital Management, Illumina Ventures and Altitude Life Science Ventures.
- DNA Script attracts $38.5 mln Series B
Paris-based DNA Script, a maker of synthetic nucleic acids, has raised $38.5 million in Series B financing. The investors included LSP, BPIFrance, Kurma Partners, Idinvest Partners, Illumina Ventures and M Ventures.
- LunaPBC attracts $4.6 mln
La Jolla, California-based LunaPBC, a provider of a genomic and health data platform, has raised $4.6 million in funding. The investors included ARCH Venture Partners, Bain Capital Ventures, F-Prime Capital, Illumina Ventures and Osage University Partners.